Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (911-920 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|January 1, 1993
Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophyC Morisco, L Argenziano, N Tozzi, et al.
Drugs|February 1, 1994
Anthracycline antibiotics in cancer therapy. Focus on drug resistanceD J Booser, G N Hortobagyi
Drugs|February 1, 1994
Changing from porcine to human insulinJ Everett, D Kerr
Drugs|February 1, 1994
Antacids. Indications and limitationsC K Ching, S K Lam
Drugs|February 1, 1994
Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthmaS M Holliday, D Faulds, E M Sorkin
Drugs|April 1, 1994
Gangliosides. Their role in clinical neurologyE Nobile-Orazio, M Carpo, G Scarlato
Drugs|April 1, 1994
Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disordersJ E Frampton, D Faulds
Drugs|April 1, 1994
Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacyR Davis, H M Bryson
Drugs|February 1, 1995
Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasiaB Fulton, A J Wagstaff, E M Sorkin
Drugs|January 1, 1994
Evolution of the arabinosides and the pharmacology of fludarabineW Plunkett, V Gandhi
Pageof 708

Showing results (911-920 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|January 1, 1993
Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophyC Morisco, L Argenziano, N Tozzi, et al.
Drugs|February 1, 1994
Anthracycline antibiotics in cancer therapy. Focus on drug resistanceD J Booser, G N Hortobagyi
Drugs|February 1, 1994
Changing from porcine to human insulinJ Everett, D Kerr
Drugs|February 1, 1994
Antacids. Indications and limitationsC K Ching, S K Lam
Drugs|February 1, 1994
Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthmaS M Holliday, D Faulds, E M Sorkin
Drugs|April 1, 1994
Gangliosides. Their role in clinical neurologyE Nobile-Orazio, M Carpo, G Scarlato
Drugs|April 1, 1994
Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disordersJ E Frampton, D Faulds
Drugs|April 1, 1994
Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacyR Davis, H M Bryson
Drugs|February 1, 1995
Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasiaB Fulton, A J Wagstaff, E M Sorkin
Drugs|January 1, 1994
Evolution of the arabinosides and the pharmacology of fludarabineW Plunkett, V Gandhi
Pageof 708